推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 12日，實驗區(qū)與福建合眾盈泰中藥材有限責(zé)任公司簽訂戰(zhàn)略合作框架協(xié)議，標(biāo)志著“世界道地中藥材電子交易服務(wù)平臺”項目正式落地平潭。
“世界道地中藥材電子交易服務(wù)平臺”是為全球優(yōu)質(zhì)道地中藥材提供電子交易、倉儲物流、供應(yīng)鏈金融等服務(wù)的第三方平臺，由世界中醫(yī)藥學(xué)會聯(lián)合會主導(dǎo)，北京合眾盈泰中藥材產(chǎn)業(yè)科技發(fā)展中心(有限合伙)(以下簡稱“北京合眾盈泰”)投資、建設(shè)。平臺致力于打造“保質(zhì)、高效、安全、便捷”公共服務(wù)環(huán)境，實現(xiàn)中藥材流通“來源可追溯、去向可查證、責(zé)任可追究”。
記者了解到，北京合眾盈泰已在平潭投資注冊福建合眾盈泰中藥材有限責(zé)任公司，負(fù)責(zé)世界道地中藥材電子交易服務(wù)平臺的投資和建設(shè)，主營中藥材及飲片、醫(yī)療器械、西藥等中西藥國際交易業(yè)務(wù)。
據(jù)介紹，該平臺落地平潭后，將積極推動平潭中藥材產(chǎn)業(yè)鏈發(fā)展，同時也將助力平潭打造大健康項目，促進(jìn)兩岸健康產(chǎn)業(yè)的交流合作。
在當(dāng)天召開的“世界道地中藥材電子交易服務(wù)平臺”項目座談會上，與會人員就如何更好地打造平臺進(jìn)行了探討，實驗區(qū)相關(guān)部門工作人員介紹了平潭平臺型總部經(jīng)濟(jì)的相關(guān)政策。實驗區(qū)黨工委委員、管委會副主任賴?yán)^秋參加會議。
